Lin, J.; Kaiser, Y.; Wiestler, B.; Bernhardt, D.; Combs, S.E.; Delbridge, C.; Meyer, B.; Gempt, J.; Aftahy, A.K.
Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients. Cancers 2023, 15, 5067.
https://doi.org/10.3390/cancers15205067
AMA Style
Lin J, Kaiser Y, Wiestler B, Bernhardt D, Combs SE, Delbridge C, Meyer B, Gempt J, Aftahy AK.
Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients. Cancers. 2023; 15(20):5067.
https://doi.org/10.3390/cancers15205067
Chicago/Turabian Style
Lin, Jonas, Yannik Kaiser, Benedikt Wiestler, Denise Bernhardt, Stephanie E. Combs, Claire Delbridge, Bernhard Meyer, Jens Gempt, and Amir Kaywan Aftahy.
2023. "Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients" Cancers 15, no. 20: 5067.
https://doi.org/10.3390/cancers15205067
APA Style
Lin, J., Kaiser, Y., Wiestler, B., Bernhardt, D., Combs, S. E., Delbridge, C., Meyer, B., Gempt, J., & Aftahy, A. K.
(2023). Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients. Cancers, 15(20), 5067.
https://doi.org/10.3390/cancers15205067
